Regina Davis
Family · Alpharetta, GANPI 1386126290
Payments from drug & device makers
Across 229 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$684
- AstraZeneca$656
- Otsuka America Pharmaceutical, Inc.$611
- Novo Nordisk$584
- GSK$392
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$229
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,690100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $684 |
| AstraZeneca | 29 | $656 |
| Otsuka America Pharmaceutical, Inc. | 28 | $611 |
| Novo Nordisk | 23 | $584 |
| GSK | 17 | $392 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $229 |
| Lilly USA, LLC | 9 | $191 |
| Lundbeck LLC | 7 | $160 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $146 |
| Pfizer | 8 | $144 |
| Boehringer Ingelheim | 5 | $121 |
| Exact Sciences | 5 | $97 |
| Idorsia Pharmaceuticals US Inc | 5 | $77 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $65 |
| Amgen | 3 | $52 |
| Dexcom, Inc. | 2 | $47 |
| Edwards Lifesciences | 2 | $46 |
| Corcept Therapeutics | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Esperion Therapeutics, Inc. | 1 | $27 |
| Mylan Specialty L.p. | 1 | $21 |
| Bardy Diagnostics, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Bayer | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,690 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 44 | $66,509 |
| OzempicSemaglutide | 45 | $46,886 |
| RybelsusSemaglutide | 15 | $26,876 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $22,687 |
| WegovySemaglutide | 13 | $22,165 |
| LinzessLinaclotide | 14 | $19,178 |
| EliquisApixaban | 18 | $18,480 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $14,111 |
| TrulicityDulaglutide | 13 | $13,378 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,035 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $10,340 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $6,478 |
| Spiriva HandihalerTiotropium Bromide | 12 | $6,184 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $5,956 |
| NexiumEsomeprazole Magnesium | 12 | $3,329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Wegovy | $584 | $95,92773 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Nexium | $656 | $80,87374 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $392 | $33,02850 claims |
| AbbVieLinzess | $684 | $19,17814 claims |
| PfizerEliquis | $144 | $18,48018 claims |
| Lilly USA, LLCTrulicity, Humulin 70-30 | $191 | $15,26026 claims |
| Boehringer IngelheimStiolto Respimat | $121 | $6,47812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Alpharetta
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.